Agios’ first-in-class PK activator Pyrukynd scores FDA approval to treat rare blood disorder Read more https://www.fiercepharma.com/pharma/agios-first-class-pk-activator-pyrukynd-scores-fda-approval-to-treat-rare-blood-disorder
